The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)

S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Lifestyle interventions for the prevention and treatment of hypertension

PL Valenzuela, P Carrera-Bastos, BG Gálvez… - Nature Reviews …, 2021 - nature.com
Hypertension affects approximately one third of the world's adult population and is a major
cause of premature death despite considerable advances in pharmacological treatments …

Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients

N Staplin, A de la Sierra, LM Ruilope, JR Emberson… - The Lancet, 2023 - thelancet.com
Background Ambulatory blood pressure provides a more comprehensive assessment than
clinic blood pressure, and has been reported to better predict health outcomes than clinic or …

Measurement of blood pressure in humans: a scientific statement from the American Heart Association

P Muntner, D Shimbo, RM Carey, JB Charleston… - …, 2019 - Am Heart Assoc
The accurate measurement of blood pressure (BP) is essential for the diagnosis and
management of hypertension. This article provides an updated American Heart Association …

Hypertension in older adults: Assessment, management, and challenges

E Oliveros, H Patel, S Kyung, S Fugar… - Clinical …, 2020 - Wiley Online Library
Hypertension in older adults is related to adverse cardiovascular outcomes, such as heart
failure, stroke, myocardial infarction, and death. The global burden of hypertension is …

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

MP Schlaich, M Bellet, MA Weber, P Danaietash… - The Lancet, 2022 - thelancet.com
Background Resistant hypertension is associated with increased cardiovascular risk. The
endothelin pathway has been implicated in the pathogenesis of hypertension, but it is …

Adherence to single-pill versus free-equivalent combination therapy in hypertension: a systematic review and meta-analysis

G Parati, S Kjeldsen, A Coca, WC Cushman… - Hypertension, 2021 - Am Heart Assoc
Poor adherence to antihypertensive therapy is a major cause of poor blood pressure (BP)
control in patients with hypertension. Regimen simplification may improve adherence and …

Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes

WY Yang, JD Melgarejo, L Thijs, ZY Zhang, J Boggia… - Jama, 2019 - jamanetwork.com
Importance Blood pressure (BP) is a known risk factor for overall mortality and
cardiovascular (CV)-specific fatal and nonfatal outcomes. It is uncertain which BP index is …

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

RC Hermida, JJ Crespo… - European heart …, 2020 - academic.oup.com
Abstract Aims The Hygia Chronotherapy Trial, conducted within the clinical primary care
setting, was designed to test whether bedtime in comparison to usual upon awakening …

Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised …

RR Townsend, F Mahfoud, DE Kandzari, K Kario… - The Lancet, 2017 - thelancet.com
Background Previous randomised renal denervation studies did not show consistent efficacy
in reducing blood pressure. The objective of our study was to evaluate the effect of renal …